Omar Abdihamid

1.3k total citations
27 papers, 197 citations indexed

About

Omar Abdihamid is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Omar Abdihamid has authored 27 papers receiving a total of 197 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Omar Abdihamid's work include CAR-T cell therapy research (5 papers), COVID-19 Clinical Research Studies (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Omar Abdihamid is often cited by papers focused on CAR-T cell therapy research (5 papers), COVID-19 Clinical Research Studies (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Omar Abdihamid collaborates with scholars based in United States, Canada and China. Omar Abdihamid's co-authors include Jinchun Wu, Yanhua Mou, Chaojun Duan, Yao Zhang, Bin Li, Changjing Cai, Shan Zeng, Hong Shen, Edward Shen and Cao Guo and has published in prestigious journals such as Blood, Gastroenterology and The Lancet Oncology.

In The Last Decade

Omar Abdihamid

22 papers receiving 195 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Omar Abdihamid United States 8 81 79 74 45 18 27 197
Huanmin Wang China 11 44 0.5× 71 0.9× 85 1.1× 48 1.1× 28 1.6× 31 260
Xiaoshan Chai China 11 32 0.4× 76 1.0× 91 1.2× 40 0.9× 24 1.3× 16 272
Jee‐Soo Lee South Korea 6 30 0.4× 62 0.8× 64 0.9× 60 1.3× 15 0.8× 24 164
Mihai Vasile Marinca Romania 8 66 0.8× 136 1.7× 57 0.8× 57 1.3× 18 1.0× 31 253
Arthi Sridhar United States 7 43 0.5× 36 0.5× 103 1.4× 25 0.6× 30 1.7× 30 198
Zhiqiang Gao China 6 134 1.7× 192 2.4× 55 0.7× 44 1.0× 5 0.3× 19 298
Silva Ljevar Italy 7 34 0.4× 131 1.7× 25 0.3× 27 0.6× 16 0.9× 17 176
Samantha Armstrong United States 10 59 0.7× 144 1.8× 82 1.1× 59 1.3× 5 0.3× 21 277
Mattéa Orsini France 5 31 0.4× 132 1.7× 37 0.5× 80 1.8× 13 0.7× 6 177
Anna Gambaro Italy 8 75 0.9× 144 1.8× 35 0.5× 63 1.4× 7 0.4× 30 199

Countries citing papers authored by Omar Abdihamid

Since Specialization
Citations

This map shows the geographic impact of Omar Abdihamid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar Abdihamid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar Abdihamid more than expected).

Fields of papers citing papers by Omar Abdihamid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omar Abdihamid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar Abdihamid. The network helps show where Omar Abdihamid may publish in the future.

Co-authorship network of co-authors of Omar Abdihamid

This figure shows the co-authorship network connecting the top 25 collaborators of Omar Abdihamid. A scholar is included among the top collaborators of Omar Abdihamid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omar Abdihamid. Omar Abdihamid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rahim, Fakher, et al.. (2025). Continuous vs. interrupted suturing in hepaticojejunostomy: a comprehensive systematic review and meta-analysis. Langenbeck s Archives of Surgery. 410(1). 214–214. 1 indexed citations
2.
Eisenhauer, Elizabeth A., Omar Abdihamid, Christopher M. Booth, et al.. (2025). Guidance for discussants of randomized cancer trials at major meetings. European Journal of Cancer. 220. 115357–115357.
3.
Abdihamid, Omar, et al.. (2025). Determinants of cancer care pathways at Wajir County, Kenya: patient perspectives. ecancermedicalscience. 19. 1841–1841. 1 indexed citations
4.
Adams, James R., et al.. (2024). Virtual surgical planning in microsurgical head and neck reconstruction: The Newcastle experience. Journal of Plastic Reconstructive & Aesthetic Surgery. 100. 254–261.
5.
Rubagumya, Fidel, et al.. (2024). Medical Tourism for Cancer Treatment: Trends, Trajectories, and Perspectives From African Countries. JCO Global Oncology. 10(10). e2400131–e2400131. 1 indexed citations
6.
Abdihamid, Omar, et al.. (2024). Landscape of esophageal cancer in Northern Kenya: experience from Garissa Regional Cancer Center. ecancermedicalscience. 18. 1694–1694. 1 indexed citations
7.
Abdihamid, Omar, Fengbo Tan, Haiyan Zhou, et al.. (2024). KIT mutations and expression: current knowledge and new insights for overcoming IM resistance in GIST. Cell Communication and Signaling. 22(1). 153–153. 13 indexed citations
8.
Bairi, Khalid El, Omar Abdihamid, Laure-Anne Teuwen, et al.. (2024). Conflict of Interest Disclosure in Oncology: Preliminary Insights From the Global ONCOTRUST-1 Cross-Sectional Study. JCO Global Oncology. 10(10). e2400167–e2400167.
9.
Abdihamid, Omar. (2023). Is congenital asymmetric crying facies really due to absence of the depressor anguli oris?. Journal of Plastic Reconstructive & Aesthetic Surgery. 82. 235–236. 1 indexed citations
10.
Rubagumya, Fidel, Miriam Mutebi, Omar Abdihamid, et al.. (2023). Pharmaceutical industry relationships with oncologists in sub-Saharan Africa. The Lancet Oncology. 24(2). e96–e101. 2 indexed citations
11.
Rubagumya, Fidel, Gad Murenzi, Omar Abdihamid, et al.. (2023). An analysis of the African cancer research ecosystem: tackling disparities. BMJ Global Health. 8(2). e011338–e011338. 10 indexed citations
12.
13.
Temesgen, Zelalem, Colleen F. Kelley, Frank Cerasoli, et al.. (2022). C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 ‘LIVE-AIR’ trial. Thorax. 78(6). thoraxjnl–2022. 8 indexed citations
14.
Abdihamid, Omar. (2022). Closing the gap in cancer care in Kenya in 2022. The Lancet Oncology. 23(6). 715–716. 2 indexed citations
15.
16.
Wu, Jinchun, Yongbin Hu, Omar Abdihamid, et al.. (2021). Crizotinib in Sarcomatous Malignancies Harboring ALK Fusion With a Definitive Partner(s): Response and Efficacy. Frontiers in Oncology. 11. 684865–684865. 6 indexed citations
17.
Kenderian, Saad S., Cameron Durrant, Dale Chappell, Omar Abdihamid, & Adrian Kilcoyne. (2021). A Phase 2/3 Randomized, Placebo-Controlled, Open-Label, Multi-Center Trial of Lenzilumab to Improve the Safety and Efficacy of CAR-T Cell Therapy in Adults with Relapsed or Refractory Large B-Cell Lymphoma (The SHIELD Study). Blood. 138(Supplement 1). 1758–1758. 5 indexed citations
18.
Abdihamid, Omar, et al.. (2020). <p>The Landscape of COVID-19 in Cancer Patients: Prevalence, Impacts, and Recommendations</p>. Cancer Management and Research. Volume 12. 8923–8933. 10 indexed citations
19.
Cox, Michelle J., Rosalie M. Sterner, Reona Sakemura, et al.. (2019). Improved Anti-Tumor Response of Chimeric Antigen Receptor T Cell (CART) Therapy after GM-CSF Inhibition Is Mechanistically Supported By a Novel Direct Interaction of GM-CSF with Activated Carts. Blood. 134(Supplement_1). 3868–3868. 3 indexed citations
20.
Patnaik, Mrinal M., David A. Sallman, Abhishek A. Mangaonkar, et al.. (2019). A Phase 1 Study of Lenzilumab, a humaneered recombinant Anti-Human Granulocyte-Macrophage Colony- Stimulating Factor (anti-hGM-CSF) Antibody, for Chronic Myelomonocytic Leukemia (CMML). Blood. 134(Supplement_1). 4234–4234. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huanmin Wang Breakdown of academic impact, for papers by Xiaoshan Chai Breakdown of academic impact, for papers by Jee‐Soo Lee Breakdown of academic impact, for papers by Mihai Vasile Marinca Breakdown of academic impact, for papers by Arthi Sridhar Breakdown of academic impact, for papers by Zhiqiang Gao Breakdown of academic impact, for papers by Silva Ljevar Breakdown of academic impact, for papers by Samantha Armstrong Breakdown of academic impact, for papers by Mattéa Orsini Breakdown of academic impact, for papers by Anna Gambaro
Rankless by CCL
2026